Floatz logo

Alisporivir

Chronic Pain

Debiopharm International SAprotein_peptidePhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

101 Active assets in the Chronic Pain cohort.

Asset / SponsorPhaseRating
(±)-TRAMADOL
EMS
Phase 4BBB
METHADONE
Cari Health Inc.
Phase 4BBB
LIDOCAINE
National and Kapodistrian University of Athens
Phase 4BBB
NEPENTHE
Bursa City Hospital
Phase 4BBB
FENTANYL
Aga Khan University
Phase 4BBB

View all 50 →

Same molecule, other indications

Alisporivir is also rated in:

hepatitis C virus infectionDormant
B
Indicative ·
57 / 100
View asset →
liver failureDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →